ORLANDO, Fla.--(BUSINESS WIRE)--A new surgical device enables breast cancer patients to be treated with dramatically improved targeting (precision) of radiation when being treated for breast cancer. Findings were presented at the 18th SIS World Congress on Breast Healthcare. The congress was co-hosted by the Senologic International Society (SIS) and the American Society of Breast Disease (ASBD).
A detailed report headed up by Linda Ann Smith, M.D., breast surgeon at Comprehensive Breast Care in Albuquerque, N.M., describes the value of more accurately targeting the site of breast cancer removal. Dr. Smith and co-author Robert Kuske, M.D. documented clinical outcomes achieved when using the new three-dimensional surgical implant (BioZorb™, Focal Therapeutics, Inc.).
Help employers find you! Check out all the jobs and post your resume.
A detailed report headed up by Linda Ann Smith, M.D., breast surgeon at Comprehensive Breast Care in Albuquerque, N.M., describes the value of more accurately targeting the site of breast cancer removal. Dr. Smith and co-author Robert Kuske, M.D. documented clinical outcomes achieved when using the new three-dimensional surgical implant (BioZorb™, Focal Therapeutics, Inc.).
Help employers find you! Check out all the jobs and post your resume.